Hua Zheng

Alnylam Pharmaceuticals (United States) — United States

Medicine · Health Sciences

23h-index3.0kcitations115works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(16), Lung Cancer Research Studies(9), RNA modifications and cancer(6), Atherosclerosis and Cardiovascular Diseases(6), Lung Cancer Diagnosis and Treatment(5)

Publications115 total

High Tacrolimus Intra‐Patient Variability and Adverse Outcomes in Cardiac Transplant Recipients: A Single‐Center Study in China
Clinical Transplantation·2025
Abstract 4362795: Vutrisiran Improved Outcomes Versus Placebo in Patients with Transthyretin Amyloidosis with Cardiomyopathy and Severe Chronic Kidney Disease: Post Hoc Analysis of HELIOS-B
Circulation·2025
#2005 Association between admission serum phosphate level and in-hospital acute kidney injury
Nephrology Dialysis Transplantation·2025Open Access
#3011 Genetic testing in chronic kidney disease: clinical and genetic insights into autosomal dominant tubulointerstitial kidney disease in a Chinese Cohort
Nephrology Dialysis Transplantation·2025Open Access
Phase I/II study of DZD6008, a 4 <sup>th</sup> -generation EGFR TKI with full BBB penetration, in EGFR-mutant NSCLC.
Journal of Clinical Oncology·2025
Arthritis care through Shared Knowledge (ASK): Evaluation of a Patient and Clinician Report to Support Treatment Decisions
2025
[The 510th case: fever of unknown origin, acute kidney injury].
PubMed·2025
Epidemiological and Clinical Characteristics of Atypical Hemolytic Uremic Syndrome in China
Journal of the American Society of Nephrology·2024
Optimal Compensation Strategy for Demand Side Response to Improve the Renewable Energy Consumption
2023
Survival Analysis of 159 Patients With Advanced Non-Small-Cell Lung Cancer Resistant to First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor
Clinical Medicine Insights Oncology·2023Open Access
Database for "Soil inorganic carbon stock and its changes across the Tibetan Plateau during the 1980s–2020s"
Figshare·2023Open Access
Database for "Soil inorganic carbon stock and its changes across the Tibetan Plateau during the 1980s–2020s"
Figshare·2023Open Access
Comparison Between the Profile of Patients Defined by Age-Adapted and Fixed-Threshold CKD Criteria: A National-Wide, Cross-Sectional Study
Journal of the American Society of Nephrology·2022
End Stage Renal Failure Patients With Hemophilia Treated With Peritoneal Dialysis: A Case Series
Kidney International Reports·2022· 1 citedOpen Access
Comparison of the profiles of patients defined by age-adapted and fixed threshold CKD criteria: a nationwide, cross-sectional study
Clinical Kidney Journal·2022· 8 citedOpen Access
mTOR participates in the formation, maintenance, and function of memory CD8+T cells regulated by glycometabolism
Biochemical Pharmacology·2022· 10 cited
Identification of biomarkers, immune infiltration landscape, and treatment targets of ischemia–reperfusion acute kidney injury at an early stage by bioinformatics methods
Hereditas·2022· 11 citedOpen Access
Optimal targets of chronic kidney disease-mineral and bone disorder markers for Chinese patients with maintenance peritoneal dialysis: a single-center retrospective cohort study
Renal Failure·2022· 9 citedOpen Access
TPX2 Serves as a Cancer Susceptibility Gene and Is Closely Associated with the Poor Prognosis of Endometrial Cancer
Genetics Research·2022· 7 citedOpen Access
A Heterozygous LMF1 Gene Mutation (c.1523C&gt;T), Combined With an LPL Gene Mutation (c.590G&gt;A), Aggravates the Clinical Symptoms in Hypertriglyceridemia
Frontiers in Genetics·2022· 6 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Limeng Chen(6), Xiaojing Ma(5), Honglei Xiao(4), Guomin Zhou(4), Prasad S. Adusumilli(4), Tongli Han(4), Opher Caspi(4), Peng Xia(4), Fang Wei(3), Baolan Li(3), Zhenjue She(3), Yun Wu(3), Virginia Wong(3), Tongmei Zhang(3), Jianfeng Lin(3), Ling Qiu(3), Peili Ji(3), Daniel Fink(2), Stefan Aebi(2), Lubin Xu(2)